Ticker Details
Viridian Therapeutics, Inc.
IPO Date:	June 16, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.57B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.51 | 2.75%
Avg Daily Range (30 D):	$0.72 | 3.19%
Avg Daily Range (90 D):	$0.61 | 2.26%

Institutional Daily Volume
Avg Daily Volume:	.63M
Avg Daily Volume (30 D):	2.33M
Avg Daily Volume (90 D):	1.55M

Trade Size
Avg Trade Size (Sh.):	68
Avg Trade Size (Sh.) (30 D):	82
Avg Trade Size (Sh.) (90 D):	71

Institutional Trades
Total Institutional Trades:	2,206
Avg Institutional Trade:	$2.17M
Avg Institutional Trade (30 D):	$3.48M
Avg Institutional Trade (90 D):	$3.09M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.1M
Avg Closing Trade (30 D):	$7.78M
Avg Closing Trade (90 D):	$6.78M
Avg Closing Volume:	152.08K

News

Apr 1, 2026 @ 5:53 PM J.Jill, Inc. Shareholders Are Encouraged to Reach ... Source: Johnson Fistel, Pllp

Mar 31, 2026 @ 3:00 PM Viridian Therapeutics, Inc. Shareholders Are Encou... Source: Johnson Fistel, Pllp

Feb 23, 2026 @ 3:26 PM Viridian Therapeutics Stock Up 75%, but One Fund J... Source: Jonathan Ponciano

Dec 31, 2025 @ 3:01 PM How M&A Unlocked A Biotech Rebound In 2025—... Source: Namrata Sen

Dec 15, 2025 @ 3:25 PM Argenx Halts Phase 3 Thyroid Eye Disease Trial, Pe... Source: Vandana Singh

Financials
	TTM	Q4 2025	FY 2025
Basic EPS
Diluted EPS
Revenue	$70.85M	$.13M	$70.85M
Gross Profit
Net Income / Loss	$-342.6M	$-120.36M	$-342.6M
Operating Income / Loss	$-363.4M	$-122.75M	$-363.4M
Cost of Revenue
Net Cash Flow	$112.79M	$42.74M	$112.79M
PE Ratio

Splits
Nov 13, 2020	1:15
Nov 07, 2016	1:15